How is West Nile virus acquired, how is it treated, and can it be transmitted between people?

West Nile Virus: Transmission, Treatment, and Person-to-Person Spread

West Nile virus is contracted primarily through bites from infected Culex mosquitoes, there is no specific antiviral treatment available (only supportive care), and it is NOT transmissible between people through casual contact—though rare non-mosquito transmission can occur through blood transfusion, organ transplantation, and from mother to fetus. 1, 2

How West Nile Virus is Contracted

Primary Transmission Route

• Mosquito bites are the overwhelming mode of transmission 1, 2
• Culex species mosquitoes spread the virus, primarily during an enzootic cycle between birds and mosquitoes 2, 3
• Humans and horses are "dead-end" or accidental hosts—we develop insufficient viremia to perpetuate the transmission cycle 4
• Peak mosquito feeding times are dawn and dusk, when exposure risk is highest 1

Rare Non-Mosquito Transmission Routes

While approximately 80% of infections occur via mosquito bites 2, documented rare transmission modes include:

• Blood transfusion: 23 confirmed cases in 2002 alone, though screening began in 2003 has reduced this dramatically (only 14 cases reported since) 2, 5
• Organ transplantation: 14 clusters identified in the US and Italy from 2002-2023 2
• Maternal-fetal transmission: Intrauterine transmission documented, with at least one case of congenital infection with severe abnormalities 1
• Breastmilk, percutaneous, and conjunctival exposure: Documented but extremely rare 2, 4

Critical point: These non-mosquito routes represent a tiny fraction of cases. The virus does NOT spread through casual person-to-person contact, respiratory droplets, or touching infected individuals.

Treatment

No Specific Antiviral Therapy Exists

The most important clinical reality is that no evidence-based antiviral treatment or cure exists for West Nile virus infection 1, 4. This is explicitly stated in CDC guidelines and remains true despite decades of research.

Current Management is Supportive Only

• Hospitalization for severe cases (neuroinvasive disease)
• Symptomatic treatment: pain control, fever management, hydration
• Neurologic monitoring and rehabilitation for complications
• No role for routine antiviral medications

Experimental Approaches (Not Standard of Care)

While several therapies have been investigated, none have shown consistent clinical efficacy 4:

• Interferon-alpha2b: Limited animal model data, no proven human benefit
• High-titer immunoglobulin: Theoretical promise but unproven
• Various small molecules and monoclonal antibodies: Still in research phases 6, 3

The absence of effective treatment makes prevention absolutely critical.

Person-to-Person Transmission

NOT Transmissible Through Casual Contact

West Nile virus does NOT spread between people through normal daily interactions 1, 2. You cannot contract it from:

• Being near an infected person
• Touching or caring for someone with WNV
• Respiratory droplets (coughing, sneezing)
• Sharing food or drinks

Medical Transmission Routes Only

The only documented person-to-person spread occurs through:

1. Blood products: Transfusion of infected red cells, platelets, or fresh-frozen plasma 5

   • Both leukoreduced and non-leukoreduced products can transmit
   • Donors may be asymptomatic at time of donation (5 of 16 implicated donors had no symptoms) 5
   • US blood supply screening since 2003 has dramatically reduced this risk

2. Solid organ transplantation: Documented in 14 clusters 2

   • Particularly concerning as recipients are immunocompromised
   • Longer incubation periods in immunocompromised recipients 5

3. Vertical transmission: Mother to fetus during pregnancy 1

   • Intrauterine infection documented
   • One case showed severe congenital abnormalities (chorioretinitis, cystic brain destruction)
   • Causal relationship not definitively proven
   • Screening of asymptomatic pregnant women is NOT recommended due to lack of treatment and unclear consequences 1

Prevention Strategies

Since treatment doesn't exist and casual transmission doesn't occur, prevention focuses entirely on avoiding mosquito bites:

Personal Protective Measures

• Use EPA-registered mosquito repellents on skin and clothing 1
• Wear protective clothing (long sleeves, pants)
• Avoid outdoor exposure during dawn and dusk when Culex mosquitoes feed most actively 1
• Use window screens and eliminate standing water around homes

Community-Level Interventions

• Integrated vector control programs 3
• WNV surveillance in mosquito and bird populations 3
• Public health alerts during high-transmission seasons

High-Risk Populations Requiring Extra Vigilance

• Adults ≥70 years: 20% mortality with neuroinvasive disease 2
• Immunocompromised patients: 30-40% mortality (hematologic malignancies, transplant recipients, those on B-cell-depleting antibodies) 2
• These groups should be especially rigorous about mosquito avoidance

Clinical Pearls

• 80% of infections are asymptomatic, 20% cause West Nile fever, and <1% cause neuroinvasive disease 2, 7
• Among hospitalized patients, 30-40% are discharged to long-term care facilities, and >50% have persistent sequelae (fatigue, weakness, memory loss) 2
• No human vaccine exists, though equine vaccines are available 2, 6
• Diagnosis requires CSF or serum IgM testing, with confirmatory neutralizing antibody testing 2, 8
• RT-PCR may be more sensitive in severely immunocompromised patients 2